Skip to main content
Equibles

Russell Investments Group, Ltd.

Position in NTLA — Intellia Therapeutics, Inc.

CIK 1692234 Seattle, WA
Back to NTLA Full portfolio

Position in NTLA

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$2,170,036
+$1,408,121 QoQ
Shares Held
128,253
+115.8% QoQ
Ownership
0.092%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#84
of 330 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 95% Shared 0% None 5%

Common Shares in NTLA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,504,360,847 across 308 Biotechnology names. NTLA ranks #85 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 336,990 $167,393,033
2 REGN
Regeneron Pharmaceuticals, Inc.
 230,151 $143,508,345
3 RPRX
Royalty Pharma plc
 1,694,250 $94,996,587
4 INCY
Incyte Corp
 425,616 $48,247,822
5 ALNY
Alnylam Pharmaceuticals, Inc.
 158,228 $47,631,369
6 BMRN
Biomarin Pharmaceutical Inc
 783,148 $44,811,725
7 LGND
Ligand Pharmaceuticals Inc
 120,304 $38,026,888
8 PTCT
Ptc Therapeutics, Inc.
 418,025 $34,098,295

All Filings in NTLA

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,170,036 128,253
2026-03-31 $761,915 59,432
2025-12-31 $86,294 9,599
2025-09-30 $195,287 11,308
2025-06-30 $12,522 1,335
2025-03-31 $59,375 8,351
2024-12-31 $1,369,056 117,415
2024-09-30 $4,079,379 198,510
2024-06-30 $3,369,934 150,578
2024-03-31 $3,032,783 110,243
2023-12-31 $3,390,609 111,204
2023-09-30 $4,024,181 127,267
2023-06-30 $4,059,117 99,537
2023-03-31 $4,113,339 110,366
2022-12-31 $2,665,525 76,398
2022-09-30 $4,609,256 82,367
2022-06-30 $5,886,456 113,726
2022-03-31 $8,096,889 111,420
2021-12-31 $9,091,946 76,894
2021-09-30 $4,444,521 33,131
2021-06-30 $4,532,993 27,997
2021-03-31 $4,295,005 53,517
2020-12-31 $4,763,971 87,573